43% of physicians paid through value-based care

Less than half—only 43 percent—of physicians say at least some of their pay comes from value-based care, according to a new survey from national physician search firm The Medicus Firm.

The survey, now in is 15th year running, reflects insight from 2,219 doctors, nurse practitioners and physician assistants across 20 medical specialties from across the country.

The results revealed that fewer than half of doctors were certain that their compensation plan included some component of value-based care, while half reported that 10 percent or less of their total income comes from value-based care.

The findings underscore that the shift from value to volume across the healthcare system still has a long way to go.

"The more things change, the more they stay the same," Jim Stone, president of The Medicus Firm, said of the study. "As the healthcare industry continually evolves, physicians have had to adapt to countless changes throughout their careers, from new technology and clinical developments, to new insurance plans, legislative changes and more. However, despite the ever-changing nature of the industry, some trends seem to consistently ring true over the years." 

Physicians were also asked their preferred type of community and region to live and work. While larger metro areas and suburban communities dominated the responses, experienced were more open to smaller communities.

Among the top most preferred practice settings, 32 percent of physicians said they prefer single-specialty groups and 20 percent preferred hospital employment, a 4 percent increase over last year’s interest in hospital employment, according to the study.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.